首站-论文投稿智能助手
典型文献
Effects of turmeric(Curcuma longa)and its constituent(curcumin)on the metabolic syndrome:An updated review
文献摘要:
Metabolic syndrome(MS)involves people with the following risk factors:obesity,hypertension,high glucose level and hyperlipidemia.It can increase the risk of heart disease,stroke and type 2 diabetes mel-litus.The prevalence of MS in the world's adult population is about 20%-25%.Today,there is much care to use medicinal plants.Turmeric(Curcuma longa)as well as curcumin which is derived from the rhizome of the plant,has been shown beneficial effects on different components of MS.Thus,the purpose of this manuscript was to introduce different in vitro,in vivo and human studies regarding the effect of turmeric and its constituent on MS.Moreover,different mechanisms of action by which this plant overcomes MS have been introduced.Based on studies,turmeric and its bioactive component,curcumin,due to their anti-inflammatory and antioxidant properties,have antidiabetic effects through increasing insulin release,antihyperlipidemic effects by increasing fatty acid uptake,anti-obesity effects by decreasing lipo-genesis,and antihypertensive effects by increasing nitric oxide.According to several in vivo,in vitro and human studies,it can be concluded that turmeric or curcumin has important values as a complementary therapy in MS.However,more clinical trials should be done to confirm these effects.
文献关键词:
作者姓名:
Zeinab Vafaeipour;Bibi Marjan Razavi;Hossein Hosseinzadeh
作者机构:
Student Research Committee,Mashhad University of Medical Sciences,Mashhad 9177948954,Iran;Department of Pharmacodynamics and Toxicology,School of Pharmacy,Mashhad University of Medical Sciences,Mashhad 9177948954,Iran;Targeted Drug Delivery Research Center,Pharmaceutical Technology Institute,Mashhad University of Medical Sciences,Mashhad 9177948954,Iran;Pharmaceutical Research Center,Pharmaceutical Technology Institute,Mashhad University of Medical Sciences,Mashhad 9177948954,Iran
引用格式:
[1]Zeinab Vafaeipour;Bibi Marjan Razavi;Hossein Hosseinzadeh-.Effects of turmeric(Curcuma longa)and its constituent(curcumin)on the metabolic syndrome:An updated review)[J].结合医学学报(英文版),2022(03):193-203
A类:
Turmeric,antihyperlipidemic
B类:
Effects,turmeric,Curcuma,longa,its,constituent,curcumin,metabolic,syndrome,An,updated,review,Metabolic,involves,people,following,risk,factors,obesity,hypertension,high,glucose,level,hyperlipidemia,It,can,increase,heart,disease,stroke,type,diabetes,mel,litus,prevalence,world,adult,population,about,Today,there,much,care,use,medicinal,plants,well,which,derived,from,rhizome,has,been,shown,beneficial,effects,different,components,Thus,purpose,this,manuscript,was,vitro,vivo,human,studies,regarding,Moreover,mechanisms,action,by,overcomes,have,introduced,Based,bioactive,due,their,inflammatory,antioxidant,properties,antidiabetic,through,increasing,insulin,release,fatty,acid,uptake,decreasing,lipo,genesis,antihypertensive,nitric,oxide,According,several,concluded,that,important,values,complementary,therapy,However,more,clinical,trials,should,done,confirm,these
AB值:
0.59453
相似文献
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Anti-inflammatory and analgesic properties of Moroccan medicinal plants:Phytochemistry,in vitro and in vivo investigations,mechanism insights,clinical evidences and perspectives
Abdelhakim Bouyahya;Fatima-Ezzahrae Guaouguaou;Nasreddine El Omari;Naoual El Menyiy;Abdelaali Balahbib;Mohamed El-Shazly;Youssef Bakri-Laboratory of Human Pathologies Biology,Department of Biology,Faculty of Sciences,and Genomic Center of Human Pathologies,Faculty of Medicine and Pharmacy,Mohammed V University in Rabat,4014,Morocco;Mohammed V University in Rabat,LPCMIO,Materials Science Center(MSC),Ecole Normale Supérieure,Rabat,1014,Morocco;Laboratory of Histology,Embryology and Cytogenetic,Faculty of Medicine and Pharmacy,Mohammed V University in Rabat,10100,Morocco;Department of Biology,Faculty of Sciences Dhar El Mahraz,University Sidi Mohamed Ben Abdellah,Fez,30003,Morocco;Laboratory of Zoology and General Biology,Faculty of Sciences,Mohammed V University in Rabat,Rabat,1014,Morocco;Department of Pharmacognosy,Faculty of Pharmacy,Ain-Shams University,Cairo,11566,Egypt;Department of Pharmaceutical Biology,Faculty of Pharmacy and Biotechnology,German University in Cairo,Cairo,11835,Egypt
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
Therapeutic potential of colchicine in cardiovascular medicine:a pharmacological review
Fan-shun Zhang;Qing-ze He;Chengxue Helena Qin;Peter J.Little;Jian-ping Weng;Suo-wen Xu-Institute of Endocrine and Metabolic Diseases,The First Affiliated Hospital of USTC,Division of Life Science and Medicine,University of Science and Technology of China,Hefei 230001,China;Faculty of Pharmacy and Pharmaceutical Sciences,Monash Institute of Pharmaceutical Sciences,Monash University(Parkville Campus),381 Royal Parade,Parkville 3052 VIC,Australia;Sunshine Coast Health Institute,University of the Sunshine Coast,Birtinya 4575 QLD,Australia;School of Pharmacy,The University of Queensland,Woolloongabba 4102 QLD,Australia;Biomedical Sciences and Health Laboratory of Anhui Province,University of Science&Technology of China,Hefei 230027,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。